About
CAR-T
Areas of Focus
Categories
Biologics & BiopharmaceuticalSan Diego & Southern California
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
60
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05370430Lead Sponsor
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
PHASE1Recruiting
36 participants
Started: Jun 13, 2022 · Completed: Jun 13, 2028
NCT04690595Lead Sponsor
BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL
PHASE1Recruiting
24 participants
Started: May 18, 2021 · Completed: Nov 18, 2027
Funding History (1)
D
Jun 12, 2018
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...